메뉴 건너뛰기
Headache
Volumn 40, Issue 5, 2000, Pages 371-372
Rizatriptan tablet versus wafer: Patient preference
Author keywords

Migraine; Oral disintegrating tablet; Rizatriptan; Tablet
Indexed keywords

ANTIMIGRAINE AGENT; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST;
EID: 0034113984     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2000.00055.x     Document Type: Article
Times cited : (21)
References (8)
  • 1
    • 0031899682 scopus 로고    scopus 로고
    • Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study
    • Teall J, Tuchman M, Cutler N, et al. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Headache. 1998;38:281-287.
    • (1998) Headache , vol.38 , pp. 281-287
    • Teall, J.1    Tuchman, M.2    Cutler, N.3
  • 2
    • 0031751088 scopus 로고    scopus 로고
    • A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
    • Kramer MS, Matzura-Wolfe D, Polis A, et al. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Neurology. 1998;51:773-781.
    • (1998) Neurology , vol.51 , pp. 773-781
    • Kramer, M.S.1    Matzura-Wolfe, D.2    Polis, A.3
  • 3
    • 0032423808 scopus 로고    scopus 로고
    • Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine
    • Goldstein J, Ryan R, Jiang K, et al. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Headache. 1998;38:737-747.
    • (1998) Headache , vol.38 , pp. 737-747
    • Goldstein, J.1    Ryan, R.2    Jiang, K.3
  • 4
    • 0032407703 scopus 로고    scopus 로고
    • Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
    • Tfelt-Hansen P, Teall J, Rodrigues F, et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache. 1998;38:748-755.
    • (1998) Headache , vol.38 , pp. 748-755
    • Tfelt-Hansen, P.1    Teall, J.2    Rodrigues, F.3
  • 5
    • 0000343693 scopus 로고    scopus 로고
    • Comparison of rizatriptan 10 mg versus zolmitriptan 2.5 mg in migraine
    • Diener HC, Pascual J, Vega P. Comparison of rizatriptan 10 mg versus zolmitriptan 2.5 mg in migraine [abstract]. Headache. 1999;39:351.
    • (1999) Headache , vol.39 , pp. 351
    • Diener, H.C.1    Pascual, J.2    Vega, P.3
  • 6
    • 0000343692 scopus 로고    scopus 로고
    • Comparison of rizatriptan 10 mg versus naratriptan 2.5 mg in migraine
    • Bornhof MK, Legg N, Paz J. Comparison of rizatriptan 10 mg versus naratriptan 2.5 mg in migraine [abstract]. Headache. 1999;39:344.
    • (1999) Headache , vol.39 , pp. 344
    • Bornhof, M.K.1    Legg, N.2    Paz, J.3
  • 7
    • 0032987716 scopus 로고    scopus 로고
    • Efficacy and safety of rizatriptan wafer for the acute treatment of migraine
    • Ahrens SP, Farmer MV, Williams DL, et al. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Cephalalgia. 1999;19:525-530.
    • (1999) Cephalalgia , vol.19 , pp. 525-530
    • Ahrens, S.P.1    Farmer, M.V.2    Williams, D.L.3
  • 8
    • 0343883089 scopus 로고    scopus 로고
    • Rizatriptan RPD for the acute treatment of migraine
    • Ahrens SP. Rizatriptan RPD for the acute treatment of migraine. Cephalalgia. 1997;18:392.
    • (1997) Cephalalgia , vol.18 , pp. 392
    • Ahrens, S.P.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.